Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

Clinical trial NCT01129336 · COMPLETED

Trial details

NCT number: NCT01129336
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

First or Second Line HER2-negative Breast Cancer Metastatic Disease Without Bone Metastasis

Start date: 2010-06-01
Primary completion: 2012-08-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.